These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 4038850)

  • 1. Use of calcium channel blockers in hypertrophic cardiomyopathy.
    Lorell BH
    Am J Med; 1985 Feb; 78(2B):43-54. PubMed ID: 4038850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy.
    Rosing DR; Idänpään-Heikkilä U; Maron BJ; Bonow RO; Epstein SE
    Am J Cardiol; 1985 Jan; 55(3):185B-195B. PubMed ID: 3881913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of calcium-channel blocking agents on left ventricular diastolic function in hypertrophic cardiomyopathy and in coronary artery disease.
    Bonow RO
    Am J Cardiol; 1985 Jan; 55(3):172B-178B. PubMed ID: 3881911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hypertrophic cardiomyopathy: relation to pathological mechanisms.
    Kaltenbach M; Hopf R
    J Mol Cell Cardiol; 1985 Jul; 17 Suppl 2():59-68. PubMed ID: 4040978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with calcium-channel blockers and beta blockers for chronic stable angina pectoris.
    Leon MB; Rosing DR; Bonow RO; Epstein SE
    Am J Cardiol; 1985 Jan; 55(3):69B-80B. PubMed ID: 2857518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertrophic obstructive cardiomyopathy. Effects of acute and chronic verapamil treatment on left ventricular systolic and diastolic function.
    Anderson DM; Raff GL; Ports TA; Brundage BH; Parmley WW; Chatterjee K
    Br Heart J; 1984 May; 51(5):523-9. PubMed ID: 6539120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of nitroprusside and nifedipine on diastolic properties in patients with hypertrophic cardiomyopathy: altered left ventricular loading or improved muscle inactivation?
    Paulus WJ; Lorell BH; Craig WE; Wynne J; Murgo JP; Grossman W
    J Am Coll Cardiol; 1983 Nov; 2(5):879-86. PubMed ID: 6685150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse effects of nifedipine therapy on hypertrophic obstructive cardiomyopathy.
    Fedor JM; Stack RS; Pryor DB; Phillips HR
    Chest; 1983 Apr; 83(4):704-6. PubMed ID: 6682029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persisting effect of Ca(2+)-channel blockers on left ventricular function in hypertrophic cardiomyopathy after 14 years' treatment.
    Hartmann A; Schnell J; Hopf R; Kneissl G
    Angiology; 1996 Aug; 47(8):765-73. PubMed ID: 8712479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects.
    Bonow RO; Dilsizian V; Rosing DR; Maron BJ; Bacharach SL; Green MV
    Circulation; 1985 Oct; 72(4):853-64. PubMed ID: 4040821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium channel blocking agents in congestive heart failure.
    Baughman KL
    Am J Med; 1986 Feb; 80(2B):46-50. PubMed ID: 3511695
    [No Abstract]   [Full Text] [Related]  

  • 13. Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy.
    Lorell BH; Paulus WJ; Grossman W; Wynne J; Cohn PF
    Circulation; 1982 Mar; 65(3):499-507. PubMed ID: 7198942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension.
    Diamond JA; Krakoff LR; Goldman A; Coplan N; Gharavi A; Martin K; Goldsmith R; Henzlova MJ; Machac J; Phillips RA
    Am J Hypertens; 2001 Mar; 14(3):231-40. PubMed ID: 11281234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical use of calcium channel blockers as ventricular unloading agents.
    Guazzi MD; Cipolla C; Sganzerla P; Agostoni PG; Fabbiocchi F; Pepi M
    Eur Heart J; 1983 Jan; 4 Suppl A():181-7. PubMed ID: 6220895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nifedipine in the treatment of hypertrophic non-obstructive cardiomyopathy].
    Senn M; Hess OM; Krayenbühl HP
    Schweiz Med Wochenschr; 1982 Sep; 112(38):1312-7. PubMed ID: 6215710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acute and chronic effects of verapamil on left ventricular function in patients with hypertrophic cardiomyopathy.
    Bonow RO; Rosing DR; Epstein SE
    Eur Heart J; 1983 Nov; 4 Suppl F():57-65. PubMed ID: 6686545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verapamil normalizes the response of left ventricular early diastolic filling to cold pressor test in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy.
    Dimitrow PP; Surdacki A; Dubiel JS
    Cardiovasc Drugs Ther; 1997 Dec; 11(6):741-6. PubMed ID: 9512868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease.
    Packer M; Medina N; Yushak M
    J Am Coll Cardiol; 1984 Nov; 4(5):890-901. PubMed ID: 6491082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy--therapy with slow channel inhibiting agents.
    Chatterjee K; Raff G; Anderson D; Parmley WW
    Prog Cardiovasc Dis; 1982; 25(3):193-210. PubMed ID: 6216500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.